Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease

IMPORTANCE: Parkinson disease (PD) is a common neurodegenerative disease. A treatment that prevents or delays development of PD is a critical unmet need. Terazosin and closely related drugs were recently discovered to enhance glycolysis and reduce PD progression in animal models and human clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales: Simmering, Jacob E., Welsh, Michael J., Liu, Lei, Narayanan, Nandakumar S., Pottegård, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851758/
https://www.ncbi.nlm.nih.gov/pubmed/33523098
http://dx.doi.org/10.1001/jamaneurol.2020.5157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851758/
https://www.ncbi.nlm.nih.gov/pubmed/33523098
http://dx.doi.org/10.1001/jamaneurol.2020.5157

Ejemplares similares